Show simple item record

dc.contributor.authorSriram, Deepa
dc.contributor.authorMcManus, Alexandra
dc.contributor.authorEmmerton, Lynne
dc.contributor.authorParsons, Richard
dc.contributor.authorJiwa, Moyez
dc.date.accessioned2017-01-30T12:57:23Z
dc.date.available2017-01-30T12:57:23Z
dc.date.created2014-05-11T20:00:22Z
dc.date.issued2014
dc.identifier.citationSriram, D. and McManus, A. and Emmerton, L. and Parsons, R. and Jiwa, M. 2014. Development and validation of a clinical decision-making aid for screening bowel symptoms in community pharmacies. Journal of Evaluation in Clinical Practice. 20 (3): pp. 260-266.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/27155
dc.identifier.doi10.1111/jep.12120
dc.description.abstract

Rationale, aims and objectives: Bowel symptoms are common, and community pharmacies are an ideal setting for health advice about these symptoms. The aim of this study was to develop and validate a questionnaire for use with adults presenting to community pharmacies with lower bowel symptoms. The purpose of the questionnaire was to stratify people into those requiring medical follow-up for symptoms and those with self-limiting symptoms. Method: A self-administered questionnaire, named the Jodi Lee test (JLT), was developed in three stages – review of the literature, questionnaire design and statistical validation – against a validated screening tool, the patient consultation questionnaire (PCQ), to assess the sensitivity and specificity of JLT. The questionnaire was developed to be simple, easy for all pharmacy staff to use and require no score calculation. Its application was designed to facilitate referral from pharmacy assistants to pharmacists and from pharmacists to medical practitioners. Results: The questionnaire comprises eight questions. It has a Flesh–Kincaid reading score of 79.5. By considering different score thresholds on the PCQ, a receiver operator characteristic (ROC) curve was calculated to assess the effectiveness of the JLT. From a sample of 118 subjects, the area under the ROC curve was 0.94. At a threshold score of 30 on the PCQ, the sensitivity was 100%. The specificity was 65%. Conclusion: The JLT has high sensitivity for identifying patients with symptoms of serious bowel disease. It is also likely to identify patients who have symptoms of relatively benign disease who would benefit from medical advice.

dc.publisherWiley-Blackwell Publishing Ltd.
dc.subjectquestionnaire
dc.subjectcommunity pharmacy
dc.subjectprimary health care
dc.subjectbowel symptoms
dc.subjectadvice
dc.subjecttriage
dc.titleDevelopment and validation of a clinical decision-making aid for screening bowel symptoms in community pharmacies
dc.typeJournal Article
dcterms.source.volume20
dcterms.source.startPage260
dcterms.source.endPage266
dcterms.source.issn1356 1294
dcterms.source.titleJournal of Evaluation in Clinical Practice
curtin.note

This is the accepted version of the following article: Sriram, D. and McManus, A. and Emmerton, L. and Parsons, R. and Jiwa, M. 2014. Development and validation of a clinical decision-making aid for screening bowel symptoms in community pharmacies. Journal of Evaluation in Clinical Practice. 20 (3): pp. 260-266, which has been published in final form at http://doi.org/10.1111/jep.12120

curtin.department
curtin.accessStatusOpen access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record